CPHI Expands to Serve Russias Rapidly Growing Pharma Market
AMSTERDAM, 9 October 2012 — Leading event organiser, UBM Live, today announced the launch of CPHI Russia at IPhEB as the latest expansion of its global pharmaceutical events. UBM Live actively sought a partnership with RESTEC, respected Russian organiser of IPhEB, the St. Petersburg International Forum for Pharmacy, Medical Equipment, Biotechnology and Radiology to facilitate access to the Russian market. The events will bring together the senior Russian pharma professionals who attend IPhEB with the global pharmaceutical suppliers and buyers who attend CPHI. The events will be co-located and held on April 10 -11, 2013 in Manege Central Exhibition Hall in St. Petersburg.
The Russian pharmaceutical market experienced high double-digit growth in recent years and is positioned firmly at the forefront of pharmerging markets. Russia is currently the eleventh largest pharmaceutical market in the world and is projected to reach a value of US $26.7 billion by the end of 2013. The Russian Government's ambitious Pharma 2020 plan, introduced in 2009, includes funding of nearly US$5 billion and seeks to dramatically increase domestic pharmaceutical manufacturing and R&D capabilities. As a result of the Pharma 2020 plan the demand for pharmaceutical ingredients and manufacturing and packaging equipment will be increasing dramatically in order to upgrade existing manufacturing sites to GMP standards.
“The Russian pharmaceutical market is set for tremendous growth: this year we already have seen leading pharmaceutical companies, such as Novartis and AstraZeneca, opening manufacturing sites and R&D centres in the St. Petersburg region and other parts of Russia. We believe our industry leading face-to-face events and digital products can play a critical role in accelerating that growth and driving innovation in the Russian pharmaceutical market,” noted Andrew Pert, Brand Director for CPHI Russia.
UBM Live’s survey results from visitors to the Frankfurt CPHI Worldwide event in 2011 showed that 42 percent of attendees were already actively working in the Russian pharmaceutical market, and more than one third had plans to enter the market over the next two years.
“We feel that this is the right time to introduce a top-level networking event that can help to facilitate successful entry into this market for our customer base and are delighted to collocate with the well established IPhEB Forum,” added Pert. In 2012 the event was strongly supported by the national government, including support from The Ministry of Industry and Trade of the Russian Federation, The Chamber of Commerce and Industry of the Russian Federation, St. Petersburg City Administration and the Committee for Economic Development, Industrial Policy and Trade.
Bringing CPHI to Russia is a logical next step after the debut of a dedicated Russian Pavilion at CPHI Worldwide 2012 with support from the Ministry of Industry and Trade of the Russian Federation. CPHI Worldwide will also host high profile exhibitors from Russia, including Indukern-Rus, R&D Pharma, P & M Invest, INVAR and Dalchem.
To learn more about CPHI Russia at IPhEB, please visit www.cphi-russia.com.
The annual UBM Live Pharma Portfolio of events also includes CPHI Worldwide, ICSE, P-MEC Europe and InnoPack (9-11 October, 2012 at the Feria de Madrid in Spain); CPHI, ICSE, P-MEC India and BioPh (21-23 November, 2012 at the Bombay Exhibition Centre in Mumbai); CPHI, P-MEC, InnoPack South East Asia (20-22 March, 2013 at the Jakarta International Expo in Indonesia); CPHI, ICSE, P-MEC, BioPh and Pharmatec Japan (24-26 April, 2013 at the Tokyo Big Sight Exhibition Centre in Japan); CPHI, P-MEC, ICSE, InnoPack, LABWorld, BioPh China (25-27 June 2013 at the SNIEC in Shanghai); and CPHI South America (6-8 August 2013 at the Expo Centre Norte, Sao Paulo, Brazil).
About UBM Live:
UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.
About RESTEC® Exhibition Company:
RESTEC® Exhibition Company is one of the top three leaders of the Russia`s exhibition business. The optimal structure formed by RESTEC® let us combine exhibition, congress, business and contest programs that altogether foster effective work of our exhibitors, participants, delegates and trade visitors. At this point our exhibition and congress events continue developing as centers of international business networking with the constantly growing number of countries and participants represented. For more information, go to www.restec.ru/en.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance